Fundraising FoxCyprium Therapeutics
New York, US · Delaware corporation · 1 known investors
Find your way into Cyprium Therapeutics
Sign up to see every warm intro you have to Cyprium Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyprium Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
Founders & leadership
Board
LA
Lindsay A. RosenwaldBoard director
Investors · 1
Frazier Life SciencesreportedPalo Alto
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2020
▶$7MraisedOct 2021 · 75 investors · Other Health CareRule 506(b)
▶$7MraisedOct 2021 · 75 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lung YamExecutive Officer
- Lindsay A. RosenwaldDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Minimum investment
- $25K
- Sales commissions
- $870K
- Placement agents
- National Securities Corporation
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Fortress BiotechFortress Biotech is a biopharmaceutical company that acquires and advances assets across therapeutic areas including oncology, dermatology, and rare diseases, generating value through product revenue, equity holdings, and dividend and royalty income. The company operates a portfolio of marketed prescription pharmaceutical products and development programs through majority-owned subsidiaries and minority ownership positions in partner companies.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as Cyprium Therapeutics.
Frequently asked questions
- What does Cyprium Therapeutics do?
- Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
- Who are Cyprium Therapeutics's investors?
- Cyprium Therapeutics's investors include Frazier Life Sciences.
- How much funding has Cyprium Therapeutics raised?
- Cyprium Therapeutics has disclosed $7M raised across 1 round.
- Where is Cyprium Therapeutics headquartered?
- Cyprium Therapeutics is headquartered in New York, US.